Dr. Faye Rim is a board certified physiatrist and pain management specialist within the Department of Anesthesiology, Critical Care & Pain Management. Dr. Rim received her medical degree from New York Medical College and completed her residency in physical medicine and rehabilitation at Mount Sinai Medical Center. She also completed a fellowship focused on pain medicine and palliative care at Memorial Sloan Kettering Cancer Center. Prior to joining HSS, Dr. Rim served as Chief of Pain and Palliative Medicine at Metropolitan Hospital.
Dr. Rim oversees the Hospital's presurgical screening pain program, where she treats patients with complex pain and controlled substance tolerance. She also works on improving preoperative screenings to ensure optimum pain management for all orthopedic patients.
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Medical Director, Presurgical Chronic Pain Management, Hospital for Special Surgery
Assistant Attending Physician, Hospital for Special Surgery
Assistant Attending Physiatrist, Hospital for Special Surgery
American Academy of Physical Medicine and Rehabilitation
Association of Academic Physiatrists
American Academy of Hospice and Palliative Medicine
Hospice and Palliative Medicine Subspecialty Through ABIM
Physical Medicine and Rehabilitation, American Board of Medical Specialties
New York Medical College, 2002
Westchester Medical Center, 2003
Mount Sinai Medical Center, 2006
Pain Medicine & Palliative Care Fellowship, Memorial Sloan Kettering Cancer Center, 2007
Sonnenblick E, Frishman WH, Sica, DA. Cardiovascular Pharmacotherapeutics. 2nd ed. New York: McGraw-Hill, Medical Pub. Division. 2003. Rim, F. Imidazoline Receptor Agonist Drugs for the Treatment of Systemic Hypertension and Congestive Heart Failure. pp. 515-526.
Sonnenblick E, Frishman WH, Sica, DA. Cardiovascular Pharmacotherapeutics. 2nd ed. New York: McGraw-Hill, Medical Pub. Division. 2003. Rim, F. Innovative Drug Targets for Treating Cardiovascular Disease: Adhesion Molecules, Cytokines, Neuropeptide Y, Calcineurin, Bradykinin, Urotensin, and Heat Shock Protein. pp. 705-740.
Panelist: Palliative Care Throughout the Community: A Continuum. New York Law School Conference Center. November 2, 2016.
Panelist: 28th Annual International Symposium on Achieving Health Equity Through Community Partnerships. Innovations in Community Based Participatory Research. April 13, 2015.
Poster: Paraneoplastic Neurologic Syndrome vs. Delirum: a case report. Toro, R, Rim F, 2017 Annual Assembly of Hospice and Palliative Care. Phoenix, AZ, February 22, 2017.
Poster: Disparities in Palliative Care among Minorities and Underserved Older Adults. Fay Rim, MD, Daniel S. Gardner, PhD, LCSW, Meredith Doherty, LCSW, Jonathan Ruiz. 2nd Annual Health Disparities Symposium, NYU Langone Medical Center, NY, NY, October 18, 2016.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of May 31, 2023, Dr. Rim reported no relationships with the healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.